BVI is a winner in the Research and Development, Investments, and Product Launches categories in the 2025 Medical Device ...

Despite the threat of a 200% tariff, most pharma stocks remained stable. US President Donald Trump’s 200% tariff threat on the pharmaceutical industry is a “shock” that will reverberate through global ...

MediView has announced the first patient enrolment in a study to assess the XR90 Holographic Surgical Navigation system.

Companion Spine has entered a definitive agreement to acquire Paradigm Spine’s business and assets from Xtant Medical Holdings.

The US Food and Drug Administration (FDA) has granted 510(k) clearance for Mendaera’s Focalist, a handheld robotic system.

Ablation therapy represents a significant innovation in cancer care. Advanced thermocouple wires are helping to deliver ...

The US FDA has approved Boston Scientific’s expanded instructions for use (IFU) labelling of the Farapulse Pulsed Field Ablation (PFA) System.

The Chinese Ministry for Commerce said the “EU has insisted on taking restrictive measures to build new protectionist barriers”.

USW researchers are set to develop biodegradable batteries that can be positioned in humans for powering medical implants.

US-based PanTher Therapeutics has initiated a trial of its chemotherapy-eluting patch, which it hopes will make cancer therapy more tolerable.

Miach Orthopaedics has completed the enrolment for the BEAR MOON study, which compares the collagen-based BEAR Implant.

Morphic Medical has obtained an EU CE mark for RESET, a device designed to target the underlying cause of obesity and type 2 diabetes (T2D).